September 10, 2025VaccinesOpen Access

Immunomodulation of Patients with Canine Visceral Leishmaniasis at Different Stages: A 12-Month Follow-Up Study Using LaSap

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Follow-up study indicates immunomodulation improves outcomes in early canine visceral leishmaniasis, highlighting resistance challenges.

Dogs in early stages of canine visceral leishmaniasis show improved immune responses compared to later stages.
The study involved 48 dogs treated with LaSap immunotherapy, with clear differences in response linked to clinical staging.
Groups of dogs received varying doses of immunotherapy over a year, revealing significant interactions with their baseline health.
Results suggest immunomodulation could enhance health in early-stage dogs, while advanced stages present treatment challenges.

Viana et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark